← Eichor
Condition: Adults With Ulcerative Colitis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Adults With Ulcerative Colitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
Phase 2 · 67 location(s) · Sanofi · NCT06975722LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Phase 2 · 147 location(s) · Eli Lilly and Company · NCT07186101A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease an
Phase N/A · 4 location(s) · AbbVie · NCT07421258Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Col
Phase 1 · 30 location(s) · Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharm · NCT06754891A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
Phase 4 · 101 location(s) · Takeda · NCT06581328A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
Phase N/A · 1 location(s) · Takeda · NCT05428345A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inf
Phase 2 · 1 location(s) · Shandong Suncadia Medicine Co., Ltd. · NCT07229950A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Col
Phase 3 · 398 location(s) · Janssen Research & Development, LLC · NCT07196748Renal Dysfunction in Patients With Inflammatory Bowel Disease and the General Population (NEPHRO-IBD)
Phase N/A · 1 location(s) · Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych · NCT07593352A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · 115 location(s) · Sanofi · NCT06867094A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Phase 2 · 207 location(s) · Eli Lilly and Company · NCT06598943An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Phase N/A · 28 location(s) · Pfizer · NCT06398626Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcer
Phase N/A · 56 location(s) · AbbVie · NCT06764706Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Def
NA · 1 location(s) · University of Thessaly · NCT07380022Study to Assess Treatment Patterns and Outcomes With Upadacitinib in Adult Participants With Inflammatory Bowel Disease
Phase N/A · 7 location(s) · AbbVie · NCT06581042A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Phase 4 · 49 location(s) · Takeda · NCT06095128LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Phase 2 · 258 location(s) · Eli Lilly and Company · NCT07415044A Safety and Pharmacokinetics Study of TL-003 in Healthy Adults and Open-label Assessments in Participants With Ulcerati
Phase 1 · 1 location(s) · TrueLab Biopharmaceutical Co., Ltd · NCT07526519Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)
Phase 2 · 28 location(s) · InSilico Medicine Hong Kong Limited · NCT07265570An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate
Phase N/A · 3 location(s) · AbbVie · NCT06838845AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis
NA · 1 location(s) · ENBIOSIS BIOTECHNOLOGIES · NCT07619638A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
Phase 2 · 16 location(s) · Takeda · NCT06764615A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Phase 2 · 71 location(s) · Eli Lilly and Company · NCT07483073A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis
Phase 2 · 15 location(s) · Merck Sharp & Dohme LLC · NCT07463183Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of
Phase 2 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT04373473Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · 189 location(s) · Eli Lilly and Company · NCT06937086
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.